Ilex Capital Partners’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,020,725
Closed -$46.6M 92
2025
Q4
$46.6M Buy
+1,020,725
New +$47.2M 1.31% 29
2024
Q2
Sell
-857,047
Closed -$37.9M 29
2024
Q1
$37.9M Sell
857,047
-380,493
-31% -$17.3M 3.72% 10
2023
Q4
$57M Buy
+1,237,540
New +$52.6M 7.97% 5

Other funds holding QGEN

Ilex Capital Partners's QGEN Position: Q1 2026 in Review

Ilex Capital Partners sold out of Qiagen (QGEN) in Q1 2026, closing a stake of 1,020,725 shares — an estimated $46.6M sold.

Ilex Capital Partners first reported a position in QGEN in Q4 2023 and held it in 3 quarters. The position peaked at $57M in Q4 2023. 343 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • Ilex Capital Partners reported no remaining Qiagen position as of Q1 2026 after selling out during the quarter.
  • Ilex Capital Partners sold 1,020,725 Qiagen shares in Q1 2026, an estimated $46.6M.
  • Ilex Capital Partners first reported a position in Qiagen in Q4 2023 and held it in 3 quarters.
  • Ilex Capital Partners's Qiagen position peaked at $57M in Q4 2023.
  • 343 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Ilex Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.